Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04144517 |
| Title | A Study of ALKS 4230 With Pembrolizumab in Head and Neck Cancer |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Alkermes, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Mural Oncology Investigational Site | Miami | Florida | 33136 | United States | Details | |
| Mural Oncology Investigational Site | Atlanta | Georgia | 30308 | United States | Details | |
| Mural Oncology Investigational Site | Minneapolis | Minnesota | 55455 | United States | Details | |
| Mural Oncology Investigational Site | New York | New York | 10016 | United States | Details | |
| Mural Oncology Investigational Site | New York | New York | 10029 | United States | Details | |
| Mural Oncology Investigational Site | Cleveland | Ohio | 44195 | United States | Details | |
| Mural Oncology Investigational Site | Austin | Texas | 78712 | United States | Details |